ctrl K

Watchlist Price Alert

Tevogen Bio Inc. (TVGN)

NASDAQ: TVGN · Real-Time Price · USD

1.27

0.00 (0.00%)

At close: Jun 17, 2025, 10:54 AM

Tevogen Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.28M	8.84K	129.19K	7.12M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	16.68M	356.86M	351.92M
Other Long-Term Assets	575.84K	n/a	-1.31M	-351.57M
Receivables	158.82K	344.5K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	919.09K	2.5K	145.17K	53.96K
Total Current Assets	2.36M	355.84K	274.36K	7.17M
Property-Plant & Equipment	524.93K	n/a	1.31M	142.62K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.1M	16.68M	356.86M	485.27K
Total Assets	3.46M	17.04M	357.14M	7.66M
Account Payables	5.2M	1.14M	210.45K	378K
Deferred Revenue	n/a	n/a	-375.81K	n/a
Short-Term Debt	1.88M	1.63M	n/a	n/a
Other Current Liabilities	403.23K	-92.39K	-856.98K	45.27K
Total Current Liabilities	9.04M	3M	350.45K	667.94K
Long-Term Debt	1M	n/a	39.3M	23.48M
Other Long-Term Liabilities	87.18K	14.49M	-25.02M	n/a
Total Long-Term Liabilities	1.09M	14.73M	14.71M	23.48M
Total Liabilities	10.14M	17.73M	15.06M	24.15M
Total Debt	2.89M	1.63M	40.01M	23.48M
Common Stock	17.8K	16.68M	356.87M	63.88K
Retained Earnings	-113.39M	-17.38M	-14.78M	-17.14M
Comprehensive Income	n/a	n/a	-0.00	n/a
Shareholders Equity	-6.67M	-695.8K	342.08M	-16.49M
Total Investments	n/a	16.68M	356.86M	351.92M